There's a new experimental drug that's showing promise in the battle against Alzheimer's. This one is different than what's currently available on the market, because it's a drug that treats the disease, rather than the symptoms.
"The whole trend in Alzheimer's research now is not just to, as we've done in the past with most of the drugs on the market, try to improve symptoms, but now that we understand the disease so much better is to try to design drugs to go in and actually affect the underlying disease itself," says John Stoukides M.D. in Geriatric and Internal Medicine.
The drug under study is called Flurizan. It attacks the toxins that are believed to cause the disease and slow its progression. Volunteers in the study take two tablets twice a day, not knowing if they're getting the real thing or a sugar pill. Researchers hope to enroll about 750 people in this National Alzheimer's Study.
If you have a loved one you think might qualify for this study, call (401) 435-8950 or you can go to Alzheimer Research Institute at www.rimmri.com.
To find out more about Flurizan, go to the manufacturer's Web site at www.myriad.com.